Suchergebnisse - "Molavipordanjani, Sajjad"

PubPharm (6)

1

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

2

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

3

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

4

The preclinical study of 177Lu-DOTA-LTVSPWY as a potential therapeutic agent against HER2 overexpressed cancer

enthalten in: Annals of nuclear medicine | 2023

von Molavipordanjani, S. | Mousavi, T. | Khorramimoghaddam, A. | +3

5

The Influence of Kidneys Ion Transport Inhibitors on the Pharmacokinetic and Tumor Uptake Behaviors of a HER2-targeted Small Size Radiolabeled Peptide

enthalten in: Current drug metabolism | 2022

von Gharibkandi, N. | Molavipordanjani, S. | Mardanshahi, A. | +1

6

99mTc-radiolabeled HER2 targeted exosome for tumor imaging

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2020

von Molavipordanjani, S. | Khodashenas, S. | Abedi, S. | +3

1
[1]